Omeros | OMER - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Adma Biologics USD 22.52M 1.5M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Gilead Sciences USD 808M 226M 2025-09
Heron Therapeutics USD 8.99M 3.02M 2025-12
Immunic USD 7.92M 25K 2025-09
Insmed USD 79.91M 316K 2025-12
Knight Therapeutics CAD 125.76M 7.63M 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 15.15M 2.54M 2025-12
Pfizer USD 5.02B 142M 2025-09
Rockwell Medical USD 1.5M 423K 2025-06
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
United Therapeutics USD 7.1M 460.9M 2025-12
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xoma USD 2.65M 1.52M 2025-09